Robuta

https://www.ajmc.com/view/challenges-in-the-management-of-c-diff-infection
Panelists take a step back to consider the broader challenges in managing patients with clostridium difficile infection.
in thec diffchallengesmanagementinfection
https://www.sciencedaily.com/releases/2018/10/181024142630.htm
A cluster of factors may help predict which patients are likely to develop Clostridioides difficile, a potentially life-threatening disease commonly known as...
c diffclusterfactorscouldhelp
https://cdiffcalc.wixsite.com/home/about
c diffcalculator
https://news.emory.edu/stories/2025/06/esc_c_diff_infections_16-06-2025/story.html
Emory computer scientist Shengpu Tang is developing artificial intelligence tools to identify, validate and transmit key data needed to better support health...
new aibest practicestoolpreventspread
https://www.drugdiscoverytrends.com/lumen-bioscience-oral-biologic-prevents-recurrent-c-diff/
Jan 19, 2024 - Lumen Bioscience is developing an oral biologic drug using a spirulina platform to prevent recurrent Clostridioides difficile infections.
c difflumenbioscienceoralbiologic
https://pastebin.com/XsyyCxzW
Pastebin.com is the number one paste tool since 2002. Pastebin is a website where you can store text online for a set period of time.
c bdiffgitnfnat
https://www.inquirer.com/health/penn-covid-vaccine-mrna-clostridium-difficile-20241030.html
Working with animals, Penn researchers modified the mRNA vaccine to target C. difficile, an infection that kills 30,000 in the U.S. each year.
covid vaccinespennresearchtargetdiff